多発性梗塞性認知症の世界市場:市場規模・現状・予測(2019-2025)

【英語タイトル】Global Multi-Infarct Dementia Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR9055422)・商品コード:QYR9055422
・発行会社(調査会社):QYResearch
・発行日:2019年8月7日(※2024年版があります。お問い合わせください)
・ページ数:99
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当資料は、多発性梗塞性認知症のグローバル市場について調査・分析したレポートで、種類別(薬理学的治療、非薬理学的治療)、用途別(学術、病院、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・多発性梗塞性認知症の世界市場規模
・主要企業別市場シェア
・多発性梗塞性認知症の世界市場規模:種類別(薬理学的治療、非薬理学的治療)
・多発性梗塞性認知症の世界市場規模:用途別(学術、病院、その他)
・多発性梗塞性認知症のアメリカ市場規模(種類別、用途別)
・多発性梗塞性認知症のヨーロッパ市場規模(種類別、用途別)
・多発性梗塞性認知症の中国市場規模(種類別、用途別)
・多発性梗塞性認知症の日本市場規模(種類別、用途別)
・多発性梗塞性認知症の東南アジア市場規模(種類別、用途別)
・多発性梗塞性認知症のインド市場規模(種類別、用途別)
・多発性梗塞性認知症の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・多発性梗塞性認知症の世界市場予測(2019年-2025年)
・多発性梗塞性認知症の地域別市場予測(2019年-2025年)
...
【レポートの概要】

Multi-cerebral infarction dementia is a series of small strokes that cause disruption of blood flow to the brain. It is the highest incidence among people over 65 years of age.The increase in the global elderly population has also contributed to the development of the global market for multi-infarct dementia.
In 2018, the global Multi-Infarct Dementia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Multi-Infarct Dementia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multi-Infarct Dementia development in United States, Europe and China.

The key players covered in this study
Forest Laboratories
Janssen Pharmaceuticals
Novartis Pharmaceutical
Pfizer
Eisai
Ortho-McNeil Pharmaceutical
Shire
Jubilant Cadista Pharmaceuticals
Takeda Pharmaceutical

Market segment by Type, the product can be split into
Pharmacological Treatment
Non Pharmacological Treatment

Market segment by Application, split into
Academic
Hospitals
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Multi-Infarct Dementia status, future forecast, growth opportunity, key market and key players.
To present the Multi-Infarct Dementia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Multi-Infarct Dementia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Multi-Infarct Dementia Market Size Growth Rate by Type (2014-2025)
1.4.2 Pharmacological Treatment
1.4.3 Non Pharmacological Treatment
1.5 Market by Application
1.5.1 Global Multi-Infarct Dementia Market Share by Application (2014-2025)
1.5.2 Academic
1.5.3 Hospitals
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Multi-Infarct Dementia Market Size
2.2 Multi-Infarct Dementia Growth Trends by Regions
2.2.1 Multi-Infarct Dementia Market Size by Regions (2014-2025)
2.2.2 Multi-Infarct Dementia Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Multi-Infarct Dementia Market Size by Manufacturers
3.1.1 Global Multi-Infarct Dementia Revenue by Manufacturers (2014-2019)
3.1.2 Global Multi-Infarct Dementia Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Multi-Infarct Dementia Market Concentration Ratio (CR5 and HHI)
3.2 Multi-Infarct Dementia Key Players Head office and Area Served
3.3 Key Players Multi-Infarct Dementia Product/Solution/Service
3.4 Date of Enter into Multi-Infarct Dementia Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Multi-Infarct Dementia Market Size by Type (2014-2019)
4.2 Global Multi-Infarct Dementia Market Size by Application (2014-2019)

5 United States
5.1 United States Multi-Infarct Dementia Market Size (2014-2019)
5.2 Multi-Infarct Dementia Key Players in United States
5.3 United States Multi-Infarct Dementia Market Size by Type
5.4 United States Multi-Infarct Dementia Market Size by Application

6 Europe
6.1 Europe Multi-Infarct Dementia Market Size (2014-2019)
6.2 Multi-Infarct Dementia Key Players in Europe
6.3 Europe Multi-Infarct Dementia Market Size by Type
6.4 Europe Multi-Infarct Dementia Market Size by Application

7 China
7.1 China Multi-Infarct Dementia Market Size (2014-2019)
7.2 Multi-Infarct Dementia Key Players in China
7.3 China Multi-Infarct Dementia Market Size by Type
7.4 China Multi-Infarct Dementia Market Size by Application

8 Japan
8.1 Japan Multi-Infarct Dementia Market Size (2014-2019)
8.2 Multi-Infarct Dementia Key Players in Japan
8.3 Japan Multi-Infarct Dementia Market Size by Type
8.4 Japan Multi-Infarct Dementia Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Multi-Infarct Dementia Market Size (2014-2019)
9.2 Multi-Infarct Dementia Key Players in Southeast Asia
9.3 Southeast Asia Multi-Infarct Dementia Market Size by Type
9.4 Southeast Asia Multi-Infarct Dementia Market Size by Application

10 India
10.1 India Multi-Infarct Dementia Market Size (2014-2019)
10.2 Multi-Infarct Dementia Key Players in India
10.3 India Multi-Infarct Dementia Market Size by Type
10.4 India Multi-Infarct Dementia Market Size by Application

11 Central & South America
11.1 Central & South America Multi-Infarct Dementia Market Size (2014-2019)
11.2 Multi-Infarct Dementia Key Players in Central & South America
11.3 Central & South America Multi-Infarct Dementia Market Size by Type
11.4 Central & South America Multi-Infarct Dementia Market Size by Application

12 International Players Profiles
12.1 Forest Laboratories
12.1.1 Forest Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Multi-Infarct Dementia Introduction
12.1.4 Forest Laboratories Revenue in Multi-Infarct Dementia Business (2014-2019)
12.1.5 Forest Laboratories Recent Development
12.2 Janssen Pharmaceuticals
12.2.1 Janssen Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Multi-Infarct Dementia Introduction
12.2.4 Janssen Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2014-2019)
12.2.5 Janssen Pharmaceuticals Recent Development
12.3 Novartis Pharmaceutical
12.3.1 Novartis Pharmaceutical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Multi-Infarct Dementia Introduction
12.3.4 Novartis Pharmaceutical Revenue in Multi-Infarct Dementia Business (2014-2019)
12.3.5 Novartis Pharmaceutical Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Multi-Infarct Dementia Introduction
12.4.4 Pfizer Revenue in Multi-Infarct Dementia Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Eisai
12.5.1 Eisai Company Details
12.5.2 Company Description and Business Overview
12.5.3 Multi-Infarct Dementia Introduction
12.5.4 Eisai Revenue in Multi-Infarct Dementia Business (2014-2019)
12.5.5 Eisai Recent Development
12.6 Ortho-McNeil Pharmaceutical
12.6.1 Ortho-McNeil Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Multi-Infarct Dementia Introduction
12.6.4 Ortho-McNeil Pharmaceutical Revenue in Multi-Infarct Dementia Business (2014-2019)
12.6.5 Ortho-McNeil Pharmaceutical Recent Development
12.7 Shire
12.7.1 Shire Company Details
12.7.2 Company Description and Business Overview
12.7.3 Multi-Infarct Dementia Introduction
12.7.4 Shire Revenue in Multi-Infarct Dementia Business (2014-2019)
12.7.5 Shire Recent Development
12.8 Jubilant Cadista Pharmaceuticals
12.8.1 Jubilant Cadista Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Multi-Infarct Dementia Introduction
12.8.4 Jubilant Cadista Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2014-2019)
12.8.5 Jubilant Cadista Pharmaceuticals Recent Development
12.9 Takeda Pharmaceutical
12.9.1 Takeda Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Multi-Infarct Dementia Introduction
12.9.4 Takeda Pharmaceutical Revenue in Multi-Infarct Dementia Business (2014-2019)
12.9.5 Takeda Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Multi-Infarct Dementia Key Market Segments
Table Key Players Multi-Infarct Dementia Covered
Table Global Multi-Infarct Dementia Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Multi-Infarct Dementia Market Size Market Share by Type 2014-2025
Figure Pharmacological Treatment Figures
Table Key Players of Pharmacological Treatment
Figure Non Pharmacological Treatment Figures
Table Key Players of Non Pharmacological Treatment
Table Global Multi-Infarct Dementia Market Size Growth by Application 2014-2025 (Million US$)
Figure Academic Case Studies
Figure Hospitals Case Studies
Figure Other Case Studies
Figure Multi-Infarct Dementia Report Years Considered
Table Global Multi-Infarct Dementia Market Size 2014-2025 (Million US$)
Figure Global Multi-Infarct Dementia Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Multi-Infarct Dementia Market Size by Regions 2014-2025 (Million US$)
Table Global Multi-Infarct Dementia Market Size by Regions 2014-2019 (Million US$)
Table Global Multi-Infarct Dementia Market Share by Regions 2014-2019
Figure Global Multi-Infarct Dementia Market Share by Regions 2014-2019
Figure Global Multi-Infarct Dementia Market Share by Regions 2019
Table Market Top Trends
Table Global Multi-Infarct Dementia Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Multi-Infarct Dementia Market Share by Manufacturers (2014-2019)
Figure Global Multi-Infarct Dementia Market Share by Manufacturers in 2018
Table Global Multi-Infarct Dementia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Multi-Infarct Dementia Product/Solution/Service
Table Date of Enter into Multi-Infarct Dementia Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Multi-Infarct Dementia Market Size by Type (2014-2019) (Million US$)
Table Global Multi-Infarct Dementia Market Size Share by Type (2014-2019)
Figure Global Multi-Infarct Dementia Market Size Market Share by Type (2014-2019)
Table Global Multi-Infarct Dementia Market Size by Application (2014-2019) (Million US$)
Table Global Multi-Infarct Dementia Market Size Share by Application (2014-2019)
Figure Global Multi-Infarct Dementia Market Size Market Share by Application (2014-2019)
Figure Global Multi-Infarct Dementia Revenue Market Share by Application in 2018
Figure United States Multi-Infarct Dementia Market Size 2014-2019 (Million US$)
Table United States Key Players Multi-Infarct Dementia Revenue (2018-2019) (Million US$)
Table United States Key Players Multi-Infarct Dementia Market Share (2018-2019)
Table United States Multi-Infarct Dementia Market Size by Type (2014-2019) (Million US$)
Table United States Multi-Infarct Dementia Market Share by Type (2014-2019)
Table United States Multi-Infarct Dementia Market Size by Application (2014-2019) (Million US$)
Table United States Multi-Infarct Dementia Market Share by Application (2014-2019)
Figure Europe Multi-Infarct Dementia Market Size 2014-2019 (Million US$)
Table Europe Key Players Multi-Infarct Dementia Revenue (2018-2019) (Million US$)
Table Europe Key Players Multi-Infarct Dementia Market Share (2018-2019)
Table Europe Multi-Infarct Dementia Market Size by Type (2014-2019) (Million US$)
Table Europe Multi-Infarct Dementia Market Share by Type (2014-2019)
Table Europe Multi-Infarct Dementia Market Size by Application (2014-2019) (Million US$)
Table Europe Multi-Infarct Dementia Market Share by Application (2014-2019)
Figure China Multi-Infarct Dementia Market Size 2014-2019 (Million US$)
Table China Key Players Multi-Infarct Dementia Revenue (2018-2019) (Million US$)
Table China Key Players Multi-Infarct Dementia Market Share (2018-2019)
Table China Multi-Infarct Dementia Market Size by Type (2014-20189) (Million US$)
Table China Multi-Infarct Dementia Market Share by Type (2014-2019)
Table China Multi-Infarct Dementia Market Size by Application (2014-2019) (Million US$)
Table China Multi-Infarct Dementia Market Share by Application (2014-2019)
Figure Japan Multi-Infarct Dementia Market Size 2014-2019 (Million US$)
Table Japan Key Players Multi-Infarct Dementia Revenue (2018-2019) (Million US$)
Table Japan Key Players Multi-Infarct Dementia Market Share (2018-2019)
Table Japan Multi-Infarct Dementia Market Size by Type (2014-2019) (Million US$)
Table Japan Multi-Infarct Dementia Market Share by Type (2014-2019)
Table Japan Multi-Infarct Dementia Market Size by Application (2014-2019) (Million US$)
Table Japan Multi-Infarct Dementia Market Share by Application (2014-2019)
Figure Southeast Asia Multi-Infarct Dementia Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Multi-Infarct Dementia Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Multi-Infarct Dementia Market Share (2018-2019)
Table Southeast Asia Multi-Infarct Dementia Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Multi-Infarct Dementia Market Share by Type (2014-2019)
Table Southeast Asia Multi-Infarct Dementia Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Multi-Infarct Dementia Market Share by Application (2014-2019)
Figure India Multi-Infarct Dementia Market Size 2014-2019 (Million US$)
Table India Key Players Multi-Infarct Dementia Revenue (2018-2019) (Million US$)
Table India Key Players Multi-Infarct Dementia Market Share (2018-2019)
Table India Multi-Infarct Dementia Market Size by Type (2014-2019) (Million US$)
Table India Multi-Infarct Dementia Market Share by Type (2014-2019)
Table India Multi-Infarct Dementia Market Size by Application (2014-2019) (Million US$)
Table India Multi-Infarct Dementia Market Share by Application (2014-2019)
Figure Central & South America Multi-Infarct Dementia Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Multi-Infarct Dementia Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Multi-Infarct Dementia Market Share (2018-2019)
Table Central & South America Multi-Infarct Dementia Market Size by Type (2014-2019) (Million US$)
Table Central & South America Multi-Infarct Dementia Market Share by Type (2014-2019)
Table Central & South America Multi-Infarct Dementia Market Size by Application (2014-2019) (Million US$)
Table Central & South America Multi-Infarct Dementia Market Share by Application (2014-2019)
Table Forest Laboratories Company Details
Table Forest Laboratories Revenue in Multi-Infarct Dementia Business (2014-2019) (Million US$)
Figure Forest Laboratories Revenue Growth Rate in Multi-Infarct Dementia Business (2014-2019)
Table Forest Laboratories Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2014-2019)(Million US$)
Figure Janssen Pharmaceuticals Revenue Growth Rate in Multi-Infarct Dementia Business (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table Novartis Pharmaceutical Company Details
Table Novartis Pharmaceutical Revenue in Multi-Infarct Dementia Business (2014-2019)(Million US$)
Figure Novartis Pharmaceutical Revenue Growth Rate in Multi-Infarct Dementia Business (2014-2019)
Table Novartis Pharmaceutical Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Multi-Infarct Dementia Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Multi-Infarct Dementia Business (2014-2019)
Table Pfizer Recent Development
Table Eisai Company Details
Table Eisai Revenue in Multi-Infarct Dementia Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Multi-Infarct Dementia Business (2014-2019)
Table Eisai Recent Development
Table Ortho-McNeil Pharmaceutical Company Details
Table Ortho-McNeil Pharmaceutical Revenue in Multi-Infarct Dementia Business (2014-2019)(Million US$)
Figure Ortho-McNeil Pharmaceutical Revenue Growth Rate in Multi-Infarct Dementia Business (2014-2019)
Table Ortho-McNeil Pharmaceutical Recent Development
Table Shire Company Details
Table Shire Revenue in Multi-Infarct Dementia Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Multi-Infarct Dementia Business (2014-2019)
Table Shire Recent Development
Table Jubilant Cadista Pharmaceuticals Company Details
Table Jubilant Cadista Pharmaceuticals Revenue in Multi-Infarct Dementia Business (2014-2019)(Million US$)
Figure Jubilant Cadista Pharmaceuticals Revenue Growth Rate in Multi-Infarct Dementia Business (2014-2019)
Table Jubilant Cadista Pharmaceuticals Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Multi-Infarct Dementia Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Multi-Infarct Dementia Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Global Multi-Infarct Dementia Market Size by Regions (Million US$) 2019-2025
Figure Global Multi-Infarct Dementia Market Size Share by Regions (2019-2025)
Figure Global Multi-Infarct Dementia Market Size Share by Regions in 2025
Figure United States Multi-Infarct Dementia Market Size Forecast (2019-2025)(Million USD)
Figure Europe Multi-Infarct Dementia Market Size Forecast (2019-2025)(Million USD)
Figure China Multi-Infarct Dementia Market Size Forecast (2019-2025)(Million USD)
Figure Japan Multi-Infarct Dementia Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Multi-Infarct Dementia Market Size Forecast (2019-2025)(Million USD)
Figure India Multi-Infarct Dementia Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Multi-Infarct Dementia Market Size Forecast (2019-2025)(Million USD)
Table Global Multi-Infarct Dementia Market Size by Product (2019-2025) (Million US$)
Figure Global Multi-Infarct Dementia Market Size by Product (2019-2025)
Figure Global Multi-Infarct Dementia Market Size by Product in 2025
Table Global Multi-Infarct Dementia Market Size by Application (2019-2025) (Million US$)
Figure Global Multi-Infarct Dementia Market Size by Application (2019-2025)
Figure Global Multi-Infarct Dementia Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


★調査レポート[多発性梗塞性認知症の世界市場:市場規模・現状・予測(2019-2025)] (コード:QYR9055422)販売に関する免責事項を必ずご確認ください。
★調査レポート[多発性梗塞性認知症の世界市場:市場規模・現状・予測(2019-2025)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆